COVID-19

Outside of the loss of human life due to the COVID-19 pandemic, the past two years have greatly affected hospitals, health systems and the way providers deliver care. Healthcare executives are grappling with federal monetary assistance, growing burnout rates, workforce shortages and federal oversight of vaccines and testing. This channel is also designed to update clinicians on new research and guidelines regarding COVID patient treatment strategies and risk assessments.

Chemical alterations in the brain hint at whether loss of smell will return post-COVID
Researchers have identified what they believe could serve as imaging biomarkers that predict recovery from anosmia after contracting the virus.
7 COVID vaccine complications: The radiologist's role in identifying adverse reactions
Although serious adverse events related to COVID-19 vaccines are rare, some are life-threatening. It is important that radiologists are aware of how these complications present.
Ultra-high field MRI implicates long COVID in brainstem damage
Researchers have used 7T MRI to demonstrate that former COVID-19 inpatients are susceptible to persistent brainstem abnormalities associated with long-haul COVID symptoms.
MRI study pinpoints neural roots of lingering fatigue post-COVID infection
Some of the findings observed have also been reported in patients who have multiple sclerosis, “which could suggest partially shared pathophysiological substrates of fatigue symptoms,” researchers indicated.
MRI findings linked to cognitive issues in patients with long COVID 2 years post-infection
The CDC estimates that just under 7% of adults in the United States continue to struggle with symptoms of long COVID.

Chemical alterations in the brain hint at whether loss of smell will return post-COVID

Researchers have identified what they believe could serve as imaging biomarkers that predict recovery from anosmia after contracting the virus.

differentiating between malignant and vaccine-related lymphadenopathy

7 COVID vaccine complications: The radiologist's role in identifying adverse reactions

Although serious adverse events related to COVID-19 vaccines are rare, some are life-threatening. It is important that radiologists are aware of how these complications present.

Ultra-high field MRI implicates long COVID in brainstem damage

Researchers have used 7T MRI to demonstrate that former COVID-19 inpatients are susceptible to persistent brainstem abnormalities associated with long-haul COVID symptoms.

MRI study pinpoints neural roots of lingering fatigue post-COVID infection

Some of the findings observed have also been reported in patients who have multiple sclerosis, “which could suggest partially shared pathophysiological substrates of fatigue symptoms,” researchers indicated.

MRI findings linked to cognitive issues in patients with long COVID 2 years post-infection

The CDC estimates that just under 7% of adults in the United States continue to struggle with symptoms of long COVID.

Loss of smell during COVID linked to structural, functional brain alterations

According to data shared by the CDC last year, around 34% of patients who contracted COVID between 2020 and 2023 reported losing their sense of smell.

COVID remnants still show up on PET/CT scans years after infection

That’s according to new PET imaging that shows the presence of activated T cells in the brain, spinal cord, gut and lung tissues of individuals who have recovered from COVID.

Imaging study reveals 'significant deformities' in lungs of some COVID patients

These changes could have long-lasting implications for lung function, authors of the new study warn.

Around the web

Radiology Business

AI can help radiology standardize image exam data labeling

To fully leverage today's radiology IT systems, standardization is a necessity. Steve Rankin, chief strategy officer for Enlitic, explains how artificial intelligence can help.

Radiology Business

The biggest obstacles facing radiology business managers in 2025

RBMA President Peter Moffatt discusses declining reimbursement rates, recruiting challenges and the role of artificial intelligence in transforming the industry.

Cardiovascular Business

New cardiac prevention paradigm explored in TRANSFORM trial using AI and CCTA

Deepak Bhatt, MD, director of the Mount Sinai Fuster Heart Hospital and principal investigator of the TRANSFORM trial, explains an emerging technique for cardiac screening: combining coronary CT angiography with artificial intelligence for plaque analysis to create an approach similar to mammography.